MAP
HAE icon

Moody Aldrich Partners’s Haemonetics HAE Stock Holding History

Moody Aldrich Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,001
Closed -$2.19M – 172
2020
Q1 		$2.19M Buy
22,001
+28
+0.1% +$3.04K 0.66% 64
2019
Q4 		$2.52M Buy
21,973
+197
+0.9% +$23.8K 0.52% 78
2019
Q3 		$2.75M Sell
21,776
-181
-0.8% -$23K 0.73% 57
2019
Q2 		$2.64M Sell
21,957
-7,969
-27% -$784K 0.68% 61
2019
Q1 		$2.62M Buy
29,926
+451
+2% +$41K 0.73% 59
2018
Q4 		$2.95M Buy
29,475
+2,054
+7% +$216K 0.97% 45
2018
Q3 		$3.14M Buy
27,421
+4,355
+19% +$451K 0.91% 52
2018
Q2 		$2.07M Buy
+23,066
New +$1.95M 0.74% 69

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moody Aldrich Partners's HAE Position: Q2 2020 in Review

Moody Aldrich Partners sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 22,001 shares — an estimated $2.19M sold.

Moody Aldrich Partners first reported a position in HAE in Q2 2018 and held it in 8 quarters. The position peaked at $3.14M in Q3 2018. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

  • Moody Aldrich Partners reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
  • Moody Aldrich Partners sold 22,001 Haemonetics shares in Q2 2020, an estimated $2.19M.
  • Moody Aldrich Partners first reported a position in Haemonetics in Q2 2018 and held it in 8 quarters.
  • Moody Aldrich Partners's Haemonetics position peaked at $3.14M in Q3 2018.
  • 285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on Moody Aldrich Partners's 13F filing for Q2 2020, filed 30 Jul 2020.